The oncologist
-
The Cancer Risk Management Model (CRMM) was used to estimate the health and economic impact of introducing stereotactic ablative radiotherapy (SABR) for stage I non-small cell lung cancer (NSCLC) in Canada. ⋯ The use of SABR for NSCLC in Canada is projected to result in significant cost savings and survival gains.